Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance
4 February 2021
Cambridge Angels
Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance
Cambridge Angels
4 February 2021

Sano Genetics, Patients Know Best, BenevolentAI, C4X Discovery Form Ulcerative Colitis Alliance

Cambridge Angels
4 February 2021

Source:https://www.genomeweb.com/informatics/sano-genetics-patients-know-best-benevolentai-c4x-discovery-form-ulcerative-colitis#.YED8bGj7SUl

Newer PostFCA approves Digital Identity Net as Registered AISP ahead of OneID pilot
Older PostOffshore energy company Rovco generates record year with £7.5m in revenues
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net